RESEARCH: HIV Adult Treatment
STRIDE: A5221 A Strategy Study of Immediate vs.Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis with CD4 <250 Cells/mm3
BHP033
Priniciple Investigator: Aida Asmelash
Funding: NIH
Objectives:
A randomized, open-label study of the AIDS Clinical Trials Group to determine whether the strategy of immediate [within approximately 2 weeks after starting treatment for tuberculosis (TB)] versus deferred (8-12 weeks after start of TB treatment) initiation of antiretroviral therapy reduces mortality and AIDS-defining events in participants being treated for TB.
Enrollment: April 2009–October 2009
Follow Up: Complete September 2010